Abu Dhabi scientists use AI to develop pain killer 'more effective than morphine'
Researchers in the UAE have used artificial intelligence to develop a pain killer that they believe could be more effective than morphine. Insilico Medicine , a clinical-stage biotechnology company with scientists working in Abu Dhabi's Masdar City, created the pill to treat acute and chronic pain. The drug, known as ISM9528, has produced promising during results initial trials and the next step…
Scientists in Abu Dhabi have employed artificial intelligence to create a painkiller, ISM9528, which may prove more effective than morphine, according to Insilico Medicine, a clinical-stage biotechnology company based in Masdar City. The pill has shown promising results in early trials, with the next step being human testing. Insilico's president and co-founder, Alex Aliper, highlighted that the drug's performance against morphine in preclinical models was unprecedented.
Aliper also noted that the drug could serve as an alternative to opioids, reducing the risk of dependence and addiction. The global pain medicine market is valued at more than $100 billion, underscoring the need for effective, non-addictive treatments. Insilico is also developing a drug to treat various cancers, including glioblastoma.
The company's AI-driven platform, Pharma.AI, launched in 2020, enables researchers to swiftly identify biological mechanisms linked to diseases, select targets, and design molecules. This approach has accelerated the drug discovery process, with Insilico aiming to nominate about one preclinical candidate per month, compared to the traditional five-year timeline.
Despite AI's role in expediting drug discovery, clinical trials still take around a decade, necessitating patient adherence to treatment.
Written by urgent.news from The National UAE's reporting — not their text. Machine-written — may contain errors; check the original before relying on it.
